Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Knobler RM and Neumann RA Exacerbation of porokeratosis during etretinate therapy. 1990 Acta Derm. Venereol. pmid:1977257
Koehn GG Dramatic follicular plugging in pityriasis rubra pilaris. 1990 J. Am. Acad. Dermatol. pmid:2212163
Matsunami E et al. Topical PUVA, etretinate, and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections. 1990 J. Dermatol. pmid:2184179
Umehara H et al. [A case of Reiter's disease with severe skin manifestations successfully treated with oral etretinate]. 1990 Ryumachi pmid:2084859
Teelmann K Testing of retinoids for systemic and topical use in human psoriasis and other disorders of keratinization: mouse papilloma test. 1990 Meth. Enzymol. pmid:2087190
Gebauer K et al. Retinoid-induced haemorrhagic bullae in Darier's disease. 1990 Australas. J. Dermatol. pmid:2095739
Larrègue M et al. [Acute pityriasis rubra pilaris in children. Treatment with etretinate (Tigason)]. 1990 Ann Dermatol Venereol pmid:2099693
Carmichael AJ and Tan CY Digitate keratoses--a complication of etretinate used in the treatment of disseminated superficial actinic porokeratosis. 1990 Clin. Exp. Dermatol. pmid:2146049
Zillikens D et al. IgA pemphigus foliaceus: a case report. 1990 Dermatologica pmid:2073960
Doran TI and Shapiro SS Retinoid effects on sebocyte proliferation. 1990 Meth. Enzymol. pmid:2087185
Korstanje MJ and van de Staak WJ Combination-therapy cyclosporin-A--etretinate for psoriasis. 1990 Clin. Exp. Dermatol. pmid:2364569
Berth-Jones J et al. A study of etretinate alopecia. 1990 Br. J. Dermatol. pmid:2369555
Telfer NR et al. Vesiculo-bullous Darier's disease. 1990 Br. J. Dermatol. pmid:2369561
Burg G and Sobetzko R [Florid oral papillomatosis: an indication for etretinate?]. 1990 Hautarzt pmid:2380067
Simon M Immunopathological aspects of etretinate therapy in lichen planus. 1990 J. Dermatol. pmid:2380432
Samsonov VA and Gareginian SA [Tigazon in the therapy of patients with circumscribed scleroderma]. 1990 Vestn Dermatol Venerol pmid:2288145
Brenner S et al. Ectropion: an adverse effect of etretinate therapy for psoriasis. 1990 DICP pmid:2244393
Petzelbauer P et al. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis. 1990 Br. J. Dermatol. pmid:2248892
Cointin M et al. [Bone complications from chronic etretinate intoxication in children]. 1990 Ann Pediatr (Paris) pmid:2256641
Zachariae H and Thestrup-Pedersen K Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. 1990 J. Invest. Dermatol. pmid:2258637
Hashimoto Y et al. [A case of xeroderma pigmentosum treated by oral etretinate]. 1990 Nihon Hifuka Gakkai Zasshi pmid:2259007
Verloes A et al. Etretinate embryotoxicity 7 months after discontinuation of treatment. 1990 Am. J. Med. Genet. pmid:2260582
Willhite CC et al. Percutaneous retinoid absorption and embryotoxicity. 1990 J. Invest. Dermatol. pmid:2230214
Deroo H et al. Darier's disease--dyskeratosis follicularis. 1990 Dermatologica pmid:2340936
Browman GP et al. Use of screening phase data to evaluate observer variation of sputum cytodiagnosis as an outcome measure in a chemoprevention trial. 1990 Cancer Res. pmid:2404590
Serri F et al. Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas. 1990 Curr. Probl. Dermatol. pmid:2404681
Granström G and Kullaa-Mikkonen A Retinoid-induced nasal malformations. 1990 ORL J. Otorhinolaryngol. Relat. Spec. pmid:2392287
Thongnopnua P et al. The pharmacokinetics of etretinate and its metabolites in the dog. 1989 Sep-Oct Drug Metab. Dispos. pmid:2573489
Kochhar DM et al. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays. 1989 Nov-Dec Drug Metab. Dispos. pmid:2575497
Brouwer KR and McNamara PJ Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies. 1989 Nov-Dec Drug Metab. Dispos. pmid:2575501
Brouwer KR and McNamara PJ Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies. 1989 Nov-Dec Drug Metab. Dispos. pmid:2575502
Simonetti O and Messini L [Effect of etretinate treatment on fluidity and lipid composition of the erythrocyte membrane in patients with psoriasis]. 1989 Nov-Dec G Ital Dermatol Venereol pmid:2638642
Vane FM et al. Identification of etretinate metabolites in human bile. 1989 May-Jun Drug Metab. Dispos. pmid:2568908
Vane FM et al. Identification of etretinate metabolites in human blood. 1989 May-Jun Drug Metab. Dispos. pmid:2568909
Ruszczak Z et al. [Laboratory and oligobiopsy studies of the liver in patients with psoriasis treated by the combination of Tigason-PUVA-cignoline (RePUVA+C)]. 1989 Mar-Apr Przegl Dermatol pmid:2695977
Hast R et al. Absent clinical effects of retinoic acid and isoretinoin treatment in the myelodysplastic syndrome. 1989 Jul-Aug Hematol Oncol pmid:2737610
Altomare G et al. [Exfoliative cytology of psoriasis: effects of cyclosporin A]. 1989 Jul-Aug G Ital Dermatol Venereol pmid:2628276
Desablens B et al. [Manifestations of Hodgkin's disease caused by retinoids?]. 1989 Jul-Aug Therapie pmid:2595650
Collin S et al. A harlequin baby survives. 1989 Jul 12-18 Nurs Times pmid:2771694
Ludera-Zimoch G and Rubisz-Brzezińska J [A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid]. 1989 Jan-Mar Przegl Dermatol pmid:2813819
Dwyer JM et al. Vasculitis and retinoids. 1989 Lancet pmid:2570197
Török L et al. Bone-scintigraphic examinations in patients treated with retinoids: a prospective study. 1989 Br. J. Dermatol. pmid:2534736
Marsden JR Lipid metabolism and retinoid therapy. 1989 Pharmacol. Ther. pmid:2645591
Hönigsmann H and Wolff K Results of therapy for psoriasis using retinoid and photochemotherapy (RePUVA). 1989 Pharmacol. Ther. pmid:2645592
Archer CB et al. Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy. 1989 Clin. Exp. Dermatol. pmid:2591100
Halkier-Sørensen L and Andresen J A retrospective study of bone changes in adults treated with etretinate. 1989 J. Am. Acad. Dermatol. pmid:2913084
DiGiovanna JJ et al. Etretinate. Persistent serum levels after long-term therapy. 1989 Arch Dermatol pmid:2913962
Lauharanta J and Geiger JM A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. 1989 Br. J. Dermatol. pmid:2527054
Larsen FG et al. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis. 1989 Pharmacol. Toxicol. pmid:2533684
Euvrard S et al. [Warts and epidermoid carcinoma after renal transplantation]. 1989 Ann Dermatol Venereol pmid:2545155
Simoni S et al. [Bullous congenital ichthyosiform erythroderma in a mother and son]. 1989 G Ital Dermatol Venereol pmid:2807392
Ward PS and Jones RD Successful treatment of a harlequin fetus. 1989 Arch. Dis. Child. pmid:2640554
Fanti PA et al. Multiple keratoacanthoma in discoid lupus erythematosus. 1989 J. Am. Acad. Dermatol. pmid:2808804
Rinck G et al. Duration of contraception after etretinate. 1989 Lancet pmid:2564929
David M et al. Keratosis lichenoides chronica with prominent telangiectasia: response to etretinate. 1989 J. Am. Acad. Dermatol. pmid:2808843
Raynaud F et al. A cAMP binding abnormality in psoriasis. 1989 Lancet pmid:2566733
Tfelt-Hansen P et al. Spinal cord compression after long-term etretinate. 1989 Lancet pmid:2569118
Harrison PV Vasculitis and retinoids. 1989 Lancet pmid:2571001
Niinimäki A et al. Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. 1989 Acta Derm. Venereol. pmid:2572115
Keukens F et al. Xeroderma pigmentosum: squamous cell carcinoma of the tongue. 1989 Acta Derm. Venereol. pmid:2575331
Magyarlaki M et al. [A case of erythrokeratodermia figurata variabilis successfully treated with tigason]. 1989 Z. Hautkr. pmid:2531508
David M et al. Erythema multiforme-like eruptions associated with etretinate therapy. 1989 Clin. Exp. Dermatol. pmid:2531640
Casado M et al. Keratoderma palmoplantaris striata. 1989 Clin. Exp. Dermatol. pmid:2531641
Boyd AS An overview of the retinoids. 1989 Am. J. Med. pmid:2653031
Rollman O et al. Etretinate and human adrenal function. 1989 J. Am. Acad. Dermatol. pmid:2536409
Yurdakök M et al. Deleterious effect of etretinate in septicemia in mice. 1989 Dermatologica pmid:2670622
Matt L et al. Newer retinoids for psoriasis--early clinical studies. 1989 Pharmacol. Ther. pmid:2645588
McLelland J and Chu AC Skin tumours in renal allograft recipient. 1989 J R Soc Med pmid:2647986
Browman GP et al. Etretinate blood levels in monitoring of compliance and contamination in a chemoprevention trial. 1989 J. Natl. Cancer Inst. pmid:2654406
Zabarino P et al. [Ossification of the antibrachial interosseous membrane caused by etretinate]. 1989 Ann Dermatol Venereol pmid:2660707
Cuny JF et al. [Rheumatologic effects of etretinate]. 1989 Ann Dermatol Venereol pmid:2660711
Stosić-Grujicić S et al. In vitro effects of Ro 10-9359 on lectin-induced activation and proliferation of T lymphocytes. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609871
Mozzato MG et al. Red blood cell membrane cation transport in normotensive psoriatics. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609881
Trevisan G et al. Psoriatic microangiopathy modifications induced by PUVA and etretinate therapy. A nail-fold capillary microscopic study. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609884
Fléchet ML et al. [Subungual multiple keratoacanthoma]. 1989 Ann Dermatol Venereol pmid:2619190
Seishima M et al. [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]. 1989 Nihon Hifuka Gakkai Zasshi pmid:2585775
Garioch J and Simpson NB Etretinate and severe nail plate dystrophies. 1989 Clin. Exp. Dermatol. pmid:2591087
Murphy GM and Griffiths WA Aphthous ulcers responding to etretinate--a case report. 1989 Clin. Exp. Dermatol. pmid:2591103
Toombs EL and Peck GL Electrosurgical treatment of etretinate-resistant Darier's disease. 1989 J Dermatol Surg Oncol pmid:2592667
Lammer E Etretinate and pregnancy. 1989 Lancet pmid:2562875
Gimenez Garcia R et al. Impetigo herpetiformis: response to steroids and etretinate. 1989 Int. J. Dermatol. pmid:2583898
Amo Bernal C et al. Morphological and biochemical alterations in growing rats induced by etretinate. 1989 Histol. Histopathol. pmid:2520476
Kellum RE Papillon-Lefèvre syndrome in four siblings treated with etretinate. A nine-year evaluation. 1989 Int. J. Dermatol. pmid:2531126
Carmichael AJ and Paul CJ Reversible gynaecomastia associated with etritinate. 1989 Br. J. Dermatol. pmid:2923800
Kelly GE et al. Effects of oral retinoid (vitamin A and etretinate) therapy on photocarcinogenesis in hairless mice. 1989 Photochem. Photobiol. pmid:2780816
Kossard S et al. Eruptive infundibulomas. A distinctive presentation of the tumor of follicular infundibulum. 1989 J. Am. Acad. Dermatol. pmid:2474013
Henderson CA and Highet AS Depression induced by etretinate. 1989 BMJ pmid:2497882
Gajardo J [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis]. 1989 Rev Med Chil pmid:2519162
Holland DB et al. Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. 1989 Skin Pharmacol. pmid:2483330
Calissendorff BM [Retinal changes--degeneration or side effect caused by etretinate (Tigason) therapy?]. 1989 Klin Monbl Augenheilkd pmid:2524625
Lowe L and Herbert AA Cystic and comedonal acne: a side effect of etretinate therapy. 1989 Int. J. Dermatol. pmid:2528515
Korstanje MJ et al. Combination therapy ciclosporin-etretinate effective in erythrodermic psoriasis. 1989 Dermatologica pmid:2529154
Gelmetti C et al. Long-term preservation of permanent teeth in a patient with Papillon-Lefèvre syndrome treated with etretinate. 1989 Pediatr Dermatol pmid:2529483
Ramsay B et al. Blistering, erosions and scarring in a patient on etretinate. 1989 Br. J. Dermatol. pmid:2529895
Martin A et al. [A new case of hyperostosis induced by a retinoid]. 1989 Rev Rhum Mal Osteoartic pmid:2688058
Gligora M et al. Psoriasis in the third age. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2692371
Klinkhoff AV et al. Pilot study of etretinate in psoriatic arthritis. 1989 J. Rheumatol. pmid:2778761
Belz J et al. Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate. 1989 J. Am. Acad. Dermatol. pmid:2785542
Rogers M and Scraf C Harlequin baby treated with etretinate. 1989 Pediatr Dermatol pmid:2798260
Kuokkanen K [Retinoid treatment of pediatric skin diseases]. 1989 Duodecim pmid:2721405